D
Daniela Cabibi
Researcher at University of Palermo
Publications - 181
Citations - 5054
Daniela Cabibi is an academic researcher from University of Palermo. The author has contributed to research in topics: Fatty liver & Liver biopsy. The author has an hindex of 32, co-authored 176 publications receiving 4300 citations.
Papers
More filters
Journal ArticleDOI
Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C
Salvatore Petta,Calogero Cammà,Concetta Scazzone,Claudio Tripodo,Vito Di Marco,Antonino Bono,Daniela Cabibi,G. Licata,Rossana Porcasi,Giulio Marchesini,Antonio Craxì +10 more
TL;DR: Low vitamin D is linked to severe fibrosis and low SVR on interferon (IFN)‐based therapy and G1 CHC patients had low 25(OH)D serum levels, possibly because of reduced CYP27A1 expression.
Journal ArticleDOI
The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease
Salvatore Petta,Marcello Maida,Fabio Salvatore Macaluso,Vito Di Marco,Calogero Cammà,Daniela Cabibi,Antonio Craxì +6 more
TL;DR: In patients with nonalcoholic fatty liver disease, the presence of severe steatosis, detected by histology or by US, should always be taken into account in order to avoid overestimations of liver fibrosis assessed by transient elastography.
Journal ArticleDOI
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
Salvatore Petta,Calogero Cammà,Vito Di Marco,N. Alessi,Daniela Cabibi,Rosalia Caldarella,Anna Licata,Fatima Maria Massenti,Giuseppe Tarantino,Giulio Marchesini,Antonio Craxì +10 more
TL;DR: In subjects with CHC resulting from G1-HCV, IR and overt diabetes are major determinants of advanced fibrosis, regardless of the degree of steatosis, mainly in the presence of severe necroinflammation.
Journal ArticleDOI
Sarcopenia is associated with severe liver fibrosis in patients with non‐alcoholic fatty liver disease
Salvatore Petta,S. Ciminnisi,V. Di Marco,Daniela Cabibi,Calogero Cammà,Anna Licata,Giulio Marchesini,Antonio Craxì +7 more
TL;DR: Sarcopenia recognises insulin resistance and obesity as risk factors, and is frequently associated with cardiometabolic disorders, including non‐alcoholic fatty liver disease (NAFLD).
Journal ArticleDOI
Reliability of liver stiffness measurement in non‐alcoholic fatty liver disease: the effects of body mass index
TL;DR: Liver stiffness measurement using transient elastography is used to stage fibrosis in patients with liver disease, diagnostic reliability and the factors affecting its performance in Patients with non‐alcoholic fatty liver disease (NAFLD) are incompletely understood.